Perinatal Mental Health
Peripartum Onset Specifier across multiple disorder categories (DSM-5-TR)
Mental health difficulties arising during pregnancy or the first year postpartum. Includes perinatal depression, perinatal anxiety, postpartum OCD, birth trauma/PTSD, bonding difficulties, perinatal grief and loss, and adjustment to parenthood. Affects approximately 1 in 5 birthing parents and is increasingly recognized as requiring specialized clinical attention.
Prevalence: ~15-20% of birthing parents; higher in low-income populations and those with prior mental health history
Clinical Picture
Perinatal mental health encompasses the psychological challenges of pregnancy, birth, and the postpartum period — including prenatal anxiety and depression, birth trauma, postpartum depression and anxiety, postpartum psychosis, and the profound identity reorganization of becoming a parent. These conditions are underdiagnosed and undertreated, in part because the cultural narrative around new parenthood leaves little room for suffering. The stakes are high: perinatal mental health affects not only the parent but the developing attachment relationship with the infant.
Treatment Considerations
IPT (Interpersonal Therapy) has the strongest evidence for perinatal depression, specifically addressing the role transitions and interpersonal changes that accompany new parenthood. CBT adaptations for perinatal mood disorders are well-supported. For birth trauma, EMDR and trauma-focused approaches can process the traumatic birth experience. Parent-infant psychotherapy addresses the attachment relationship directly when the parent's mental health is affecting their capacity to attune to the baby. Screening (Edinburgh Postnatal Depression Scale) should be routine. Medication decisions during pregnancy and breastfeeding require careful risk-benefit analysis with psychiatric consultation.
7 Therapeutic Approaches
Sorted by evidence tier: guideline-recommended first, then RCT-supported, then emerging/limited evidence.
Related Clinical Vignettes
Sources & References
Prevalence data from NIMH, WHO, and DSM-5-TR field trial publications. Evidence tiers reflect guideline status (APA, NICE, VA/DoD, WHO) and meta-analytic findings as of early 2025. Individual modality citations are listed on each modality page. Full bibliography available on the Sources page.